Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2009 1
2011 1
2013 1
2014 3
2015 2
2018 3
2019 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
HGF/MET and the Immune System: Relevance for Cancer Immunotherapy.
Papaccio F, Della Corte CM, Viscardi G, Di Liello R, Esposito G, Sparano F, Ciardiello F, Morgillo F. Papaccio F, et al. Int J Mol Sci. 2018 Nov 14;19(11):3595. doi: 10.3390/ijms19113595. Int J Mol Sci. 2018. PMID: 30441809 Free PMC article. Review.
Resistance mechanisms of tumour cells to EGFR inhibitors.
Morgillo F, Cantile F, Fasano M, Troiani T, Martinelli E, Ciardiello F. Morgillo F, et al. Clin Transl Oncol. 2009 May;11(5):270-5. doi: 10.1007/s12094-009-0354-6. Clin Transl Oncol. 2009. PMID: 19451059 Review.
Antitumor Efficacy of Dual Blockade of EGFR Signaling by Osimertinib in Combination With Selumetinib or Cetuximab in Activated EGFR Human NCLC Tumor Models.
Della Corte CM, Ciaramella V, Cardone C, La Monica S, Alfieri R, Petronini PG, Malapelle U, Vigliar E, Pepe F, Troncone G, Castellone MD, Troiani T, Martinelli E, Ciardiello F, Morgillo F. Della Corte CM, et al. J Thorac Oncol. 2018 Jun;13(6):810-820. doi: 10.1016/j.jtho.2018.02.025. Epub 2018 Mar 8. J Thorac Oncol. 2018. PMID: 29526823 Free article.
A multicenter, open-label phase II study of metformin with erlotinib in second-line therapy of stage IV non-small-cell lung cancer patients: treatment rationale and protocol dynamics of the METAL trial.
Fasano M, Della Corte CM, Capuano A, Sasso FC, Papaccio F, Berrino L, Ciardiello F, Morgillo F. Fasano M, et al. Clin Lung Cancer. 2015 Jan;16(1):57-9. doi: 10.1016/j.cllc.2014.06.010. Epub 2014 Aug 17. Clin Lung Cancer. 2015. PMID: 25242667 Clinical Trial.
12 results